Search
for
Sort by
Research 211–240 of 1000+
- Multidimensional assessment of adverse events of finasteride:a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic data
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Comprehension Testing for OTC Drug Labels: Goals, Methods, Target Population, and Testing Environment
- Antihelminthic Drugs
- Dermatological drugs, topical agents, and cosmetics
- Hormone Blocking Anticancer Drugs
- Drug pipeline 2Q22 — a downturn in approvals
- The PDGF/PDGFR pathway as a drug target
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Real-world study of adverse events associated with gepant use in migraine treatment based on the VigiAccess and U.S. Food and Drug Administration’s adverse event reporting system databases
- Off-label prescriptions: patient safety first
- Digoxin-induced anemia among patients with atrial fibrillation and heart failure: clinical data analysis and drug-gene interaction network
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Incidence and management of cutaneous toxicities associated with cetuximab
- Neuropsychiatric Adverse Events of Montelukast: An Analysis of Real-World Datasets and drug−gene Interaction Network
- Updates on Therapeutic Approaches for Management of Androgenetic Alopecia: A Review
- Review of the effects of 17α-estradiol in humans: a less feminizing estrogen with neuroprotective potential
- A review on computer‐aided chemogenomics and drug repositioning for rationalCOVID‐19 drug discovery
- Proposed mechanisms of low-level light therapy in the treatment of androgenetic alopecia
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Response: Finasteride's Effect on Frontal and Vertex Hair Loss
- An excellent response to tofacitinib in a Brazilian adolescent patient with alopecia areata: A case report and a review of the literature
- Journal of Pigmentary Disorders
- Minoxidil tópico o minoxidil oral en la alopecia. ¿Cuál es su elección?
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- Investigational medications in the treatment of alopecia